Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen A Martins

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2024
Marburg Virus Medical CountermeasuresKaren A Martins, Daniel N Wolfe
Expert Review of Vaccines|May 11, 2016
Ebola virus disease candidate vaccines under evaluation in clinical trialsKaren A Martins, Peter B Jahrling, Sina Bavari, et al.
Annual Review of Pharmacology and Toxicology|December 14, 2016
Will There Be a Cure for Ebola?Anthony P Cardile, Travis K Warren, Karen A Martins, et al.
Vaccine|May 19, 2020
Adjuvant selection impacts the correlates of vaccine protection against Ebola infectionSabrina M Stronsky, Christopher L Cooper, Jesse Steffens, et al.
Emerging Microbes & Infections|June 8, 2017
T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protectionChristopher L Cooper, Karen A Martins, Sabrina M Stronsky, et al.
Health Security|August 11, 2018
Distinguishing Respiratory Features of Category A/B Potential Bioterrorism Agents from Community-Acquired PneumoniaElena H Kwon, Ronald B Reisler, Anthony P Cardile, et al.
The American Journal of Tropical Medicine and Hygiene|April 25, 2019
Neutralizing Antibodies from Convalescent Chikungunya Virus Patients Can Cross-Neutralize Mayaro and Una VirusesKaren A Martins, Melissa K Gregory, Stephanie M Valdez, et al.
Vaccines|August 26, 2022
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next StepsIan Crozier, Kyla A Britson, Daniel N Wolfe, et al.
The Journal of Infectious Diseases|August 19, 2023
Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector MeetingArmand Sprecher, Robert Cross, Andrea Marzi, et al.
Health Security|April 24, 2020
Pre-positioned Outbreak Research: The Joint Medical Emerging Diseases Intervention Clinical Capability Experience in UgandaKaren A Martins, Rodgers R Ayebare, Nahid Bhadelia, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2024
Marburg Virus Medical CountermeasuresKaren A Martins, Daniel N Wolfe
Expert Review of Vaccines|May 11, 2016
Ebola virus disease candidate vaccines under evaluation in clinical trialsKaren A Martins, Peter B Jahrling, Sina Bavari, et al.
Annual Review of Pharmacology and Toxicology|December 14, 2016
Will There Be a Cure for Ebola?Anthony P Cardile, Travis K Warren, Karen A Martins, et al.
Vaccine|May 19, 2020
Adjuvant selection impacts the correlates of vaccine protection against Ebola infectionSabrina M Stronsky, Christopher L Cooper, Jesse Steffens, et al.
Emerging Microbes & Infections|June 8, 2017
T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protectionChristopher L Cooper, Karen A Martins, Sabrina M Stronsky, et al.
Health Security|August 11, 2018
Distinguishing Respiratory Features of Category A/B Potential Bioterrorism Agents from Community-Acquired PneumoniaElena H Kwon, Ronald B Reisler, Anthony P Cardile, et al.
The American Journal of Tropical Medicine and Hygiene|April 25, 2019
Neutralizing Antibodies from Convalescent Chikungunya Virus Patients Can Cross-Neutralize Mayaro and Una VirusesKaren A Martins, Melissa K Gregory, Stephanie M Valdez, et al.
Vaccines|August 26, 2022
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next StepsIan Crozier, Kyla A Britson, Daniel N Wolfe, et al.
The Journal of Infectious Diseases|August 19, 2023
Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector MeetingArmand Sprecher, Robert Cross, Andrea Marzi, et al.
Health Security|April 24, 2020
Pre-positioned Outbreak Research: The Joint Medical Emerging Diseases Intervention Clinical Capability Experience in UgandaKaren A Martins, Rodgers R Ayebare, Nahid Bhadelia, et al.
Pageof 2